Feb 2018

CALL FOR EASIER ACCESS TO CANNABIS FOR CHRONIC PAIN SUFFERERS

Liberal Democrats Senator David Leyonhjelm is pushing for the Federal Government to break the barriers preventing thousands of Australians suffering from chronic pain from accessing medicinal cannabis. Senator Leyonhjelm comments come ahead of HEMP Embassy campaigners protesting against the restrictions on cannabis use as the prescription-only rules for codeine come into effect.

Senator Leyonhjelm commented that “it has now become a matter of urgency that seriously ill patients obtain access to an effective and safe alternative.”

Read the article here.

 

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

What’s most important in business – purpose or profit? At ANTG we get to achieve both.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >